Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
SCANZI, Julien
IBSET, NCT02973542 / 2016-002110-42: Ethosuximide to Treat IBS	Active, not recruiting	2	162	Europe	Ethosuximide, Placebo	University Hospital, Clermont-Ferrand, SFETD (Socièté Française d'Etude et de Traitement de la Douleur)	Irritable Bowel Syndrome	04/23	05/23
LIVEDIFF, NCT06306014: Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients	Recruiting	1/2	56	Europe	EXL01, Placebo	Hospices Civils de Lyon, Exeliom Biosciences	Clostridioides Difficile Infection, Recurrent Infection	01/27	01/27
Deeper, NCT04973423: STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP	Recruiting	N/A	180	Europe	MRI	University Hospital, Clermont-Ferrand	Crohn Disease, Calprotectin, MRI	03/27	08/27